1. Home
  2. BRN vs DARE Comparison

BRN vs DARE Comparison

Compare BRN & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnwell Industries Inc.

BRN

Barnwell Industries Inc.

N/A

Current Price

$0.99

Market Cap

14.8M

Sector

Energy

ML Signal

N/A

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$0.78

Market Cap

13.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRN
DARE
Founded
1956
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
13.9M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
BRN
DARE
Price
$0.99
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
43.2K
339.2K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,697,000.00
$2,807,885.00
Revenue This Year
N/A
$2,115.12
Revenue Next Year
N/A
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$0.69
52 Week High
$1.40
$3.78

Technical Indicators

Market Signals
Indicator
BRN
DARE
Relative Strength Index (RSI) 60.17 39.19
Support Level $0.97 $0.75
Resistance Level $1.11 $2.21
Average True Range (ATR) 0.04 0.05
MACD 0.01 0.03
Stochastic Oscillator 83.24 70.23

Price Performance

Historical Comparison
BRN
DARE

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: